FDA Drug Recalls

Recalls / Class II

Class IID-0186-2025

Product

Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10

Brand name
Progesterone
Generic name
Progesterone
Active ingredient
Progesterone
Route
Intramuscular
NDC
55150-306
FDA application
ANDA210965
Affected lot / code info
Batch # 1PR24010, Expiry: 02/28/2027

Why it was recalled

Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

Recalling firm

Firm
Eugia US LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
279 Princeton Hightstown Rd, East Windsor, New Jersey 08520-1401

Distribution

Quantity
17,300 10-mL vials
Distribution pattern
Distributed Nationwide in the USA.

Timeline

Recall initiated
2024-12-27
FDA classified
2025-01-07
Posted by FDA
2025-01-15
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0186-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.